Company Filing History:
Years Active: 2017-2021
Title: Changhua Ji: Innovator in Antibody Technology
Introduction
Changhua Ji is a prominent inventor based in Livingston, NJ (US). He has made significant contributions to the field of biotechnology, particularly in the development of antibodies that target specific receptors. With a total of 3 patents to his name, Ji's work is paving the way for advancements in medical treatments.
Latest Patents
One of Ji's latest patents is focused on ASPGR antibodies and their uses. This invention relates to antibodies that are specific for the asialoglycoprotein receptor (ASGPR). These antibodies are designed for selectively delivering effector moieties that can influence cellular activity. The patent also covers polynucleotides encoding such antibodies, as well as vectors and host cells that comprise these polynucleotides. Furthermore, the invention outlines methods for producing these antibodies and their applications in treating diseases.
Career Highlights
Changhua Ji is currently associated with Roche Glycart AG, where he continues to innovate in the field of antibody technology. His work has been instrumental in advancing therapeutic options for various diseases. Ji's expertise and dedication to research have established him as a key figure in his field.
Collaborations
Some of Ji's notable coworkers include Thomas U Hofer and Ekkehard Moessner. Their collaborative efforts contribute to the ongoing research and development of innovative solutions in biotechnology.
Conclusion
Changhua Ji's contributions to antibody technology exemplify the impact of innovation in the medical field. His patents and ongoing work at Roche Glycart AG highlight the importance of targeted therapies in improving patient outcomes.